From Lab to Market

Discover the spin-offs shaping the future of MedTech and BioTech. We transform academic excellence into global impact.

Featured Spin-offs

Pioneering ventures born from rigorous academic research, now scaling to solve critical healthcare challenges.

Launch year : 2020

Medical Imaging

Synthetic antibodies for autoimmune disease management.

Acquired

Launch year : 2021

Medical Imaging

Nanoparticle drug delivery systems for targeted oncology treatments.

Patented Tech

Launch year : 2022

Medical Imaging

AI-driven predictive modeling for cardiovascular events.

50k+ Patients

Launch year : 2020

BioTech

Wearable biosensors for real-time metabolic monitoring.

FDA Cleared

Launch year : 2021

Biotools

CRISPR-based targeted therapies for rare genetic disorders.

3 Clinical Trials

Launch year : 2022

Biotools

Next-generation neural interfaces for advanced prosthetics and rehabilitation.

$12M Series A

Whether you’re looking to invest in breakthrough technologies or partner with our leading researchers, PACTT is your gateway to innovation.